Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans.

Lorthioir A, Joannidès R, Rémy-Jouet I, Fréguin-Bouilland C, Iacob M, Roche C, Monteil C, Lucas D, Renet S, Audrézet MP, Godin M, Richard V, Thuillez C, Guerrot D, Bellien J.

Kidney Int. 2015 Feb;87(2):465-72. doi: 10.1038/ki.2014.241. Epub 2014 Jul 16.

PMID:
25029430
2.

Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades.

AbouAlaiwi WA, Takahashi M, Mell BR, Jones TJ, Ratnam S, Kolb RJ, Nauli SM.

Circ Res. 2009 Apr 10;104(7):860-9. doi: 10.1161/CIRCRESAHA.108.192765. Epub 2009 Mar 5.

3.
4.

Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.

Bellien J, Iacob M, Remy-Jouet I, Lucas D, Monteil C, Gutierrez L, Vendeville C, Dreano Y, Mercier A, Thuillez C, Joannides R.

Circulation. 2012 Mar 13;125(10):1266-75. doi: 10.1161/CIRCULATIONAHA.111.070680.

PMID:
22412088
5.

Does dopamine connect the dots in ADPKD?

Chapman AB.

Kidney Int. 2015 Feb;87(2):279-80. doi: 10.1038/ki.2014.391.

PMID:
25635722
6.
7.
8.

Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease.

Clausen P, Feldt-Rasmussen B, Iversen J, Lange M, Eidemak I, Strandgaard S.

Am J Nephrol. 2006;26(4):335-9. Epub 2006 Jul 5.

PMID:
16825759
9.

Exercise capacity in polycystic kidney disease.

Reinecke NL, Cunha TM, Heilberg IP, Higa EM, Nishiura JL, Neder JA, Almeida WS, Schor N.

Am J Kidney Dis. 2014 Aug;64(2):239-46. doi: 10.1053/j.ajkd.2014.03.014. Epub 2014 Apr 29.

PMID:
24787761
10.

Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.

Nowak KL, Farmer H, Cadnapaphornchai MA, Gitomer B, Chonchol M.

Nephrol Dial Transplant. 2017 Feb 1;32(2):342-347. doi: 10.1093/ndt/gfw013.

11.
12.

Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.

Nauli SM, Rossetti S, Kolb RJ, Alenghat FJ, Consugar MB, Harris PC, Ingber DE, Loghman-Adham M, Zhou J.

J Am Soc Nephrol. 2006 Apr;17(4):1015-25.

13.

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.

Duflot T, Moreau-Grangé L, Roche C, Iacob M, Wils J, Rémy-Jouet I, Cailleux AF, Leuillier M, Renet S, Li D, Morisseau C, Lamoureux F, Richard V, Prévost G, Joannidès R, Bellien J.

Cardiovasc Diabetol. 2019 Mar 18;18(1):35. doi: 10.1186/s12933-019-0843-z.

14.

Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1.

Nauli SM, Kawanabe Y, Kaminski JJ, Pearce WJ, Ingber DE, Zhou J.

Circulation. 2008 Mar 4;117(9):1161-71. doi: 10.1161/CIRCULATIONAHA.107.710111. Epub 2008 Feb 19.

15.

Plasma nitrate levels and flow-mediated vasodilation in untreated major depression.

García RG, Zarruk JG, Barrera C, Pinzón A, Trillos E, Arenas WD, Luengas C, Tomaz C, López-Jaramillo P.

Psychosom Med. 2011 May;73(4):344-9. doi: 10.1097/PSY.0b013e31821566cf. Epub 2011 May 2.

PMID:
21536836
16.

[Cardiovascular risk in polycystic kidney disease].

Di Lorenzo A, Stallone G, Infante B, Grandaliano G, Schena FP.

G Ital Cardiol (Rome). 2015 Sep;16(9):479-84. doi: 10.1714/1988.21520. Italian.

PMID:
26418387
17.
18.

Early stage detection of conduit artery endothelial dysfunction in patients with type 1 diabetes.

Bellien J, Costentin A, Dutheil-Maillochaud B, Iacob M, Kuhn JM, Thuillez C, Joannides R.

Diab Vasc Dis Res. 2010 Apr;7(2):158-66. doi: 10.1177/1479164109360470. Epub 2010 Feb 22.

PMID:
20382780
19.

Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Ecder T, Schrier RW.

Nat Rev Nephrol. 2009 Apr;5(4):221-8. doi: 10.1038/nrneph.2009.13. Review.

20.

Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.

Cai Y, Tang Z.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Feb;35(2):93-9. doi: 10.3969/j.issn.1672-7347.2010.02.001. Review.

Supplemental Content

Support Center